{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T22:59:20Z","timestamp":1793314760432,"version":"4.5.0"},"reference-count":81,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007816","name":"Alcon","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007819","name":"Allergan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007819","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016960","name":"Tec Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016960","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004321","name":"Shire","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Ocular Surface"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jtos.2022.08.010","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T22:35:17Z","timestamp":1663626917000},"page":"211-221","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Antibiotic treatment for dry eye disease related to meibomian gland dysfunction and blepharitis \u2013 A review"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5736-8031","authenticated-orcid":false,"given":"Ragnheidur R.","family":"Vernhardsdottir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten S.","family":"Magno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Hynnekleiv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Lagali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlene A.","family":"Dartt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jelle","family":"Vehof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tor P.","family":"Utheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib1","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1167\/iovs.10-6997g","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on management and treatment of meibomian gland dysfunction","volume":"52","author":"Geerling","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib2","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","article-title":"TFOS DEWS II epidemiology report","volume":"15","author":"Stapleton","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jtos.2017.05.011","article-title":"TFOS DEWS II pathophysiology report","volume":"15","author":"Bron","year":"2017","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib4","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.jtos.2017.04.001","article-title":"TFOS DEWS II sex, gender, and hormones report","volume":"15","author":"Sullivan","year":"2017","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib5","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ajo.2013.05.040","article-title":"Prevalence of dry eye disease and its risk factors in visual display terminal users: the Osaka study","volume":"156","author":"Uchino","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.010_bib6","series-title":"Population division. World population ageing 2019: highlights","author":"United Nations DoEaSA","year":"2019"},{"key":"10.1016\/j.jtos.2022.08.010_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ajo.2020.07.034","article-title":"Digital screen time during the COVID-19 pandemic: risk for a further myopia boom?","volume":"223","author":"Wong","year":"2020","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.010_bib8","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jtos.2021.05.006","article-title":"The physical and mental burden of dry eye disease: a large population-based study investigating the relationship with health-related quality of life and its determinants","volume":"21","author":"Morthen","year":"2021","journal-title":"Ocul Surf"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib9","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/ICO.0b013e3181f7f363","article-title":"The economic burden of dry eye disease in the United States: a decision tree analysis","volume":"30","author":"Yu","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.010_bib10","series-title":"Kanski's clinical ophthalmology : a systematic approach","author":"Bowling","year":"2016"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jtos.2017.05.006","article-title":"TFOS DEWS II management and therapy report","volume":"15","author":"Jones","year":"2017","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jtos.2022.08.010_bib12","series-title":"Antibiotic resistance","year":"2020"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib13","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ophtha.2015.10.062","article-title":"Oral antibiotics for meibomian gland-related ocular surface disease: a report by the American academy of ophthalmology","volume":"123","author":"Wladis","year":"2016","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.survophthal.2019.08.007","article-title":"Management of meibomian gland dysfunction: a review","volume":"65","author":"Sabeti","year":"2020","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/ICL.0000000000000680","article-title":"A review on evidence-based treatments for meibomian gland dysfunction","volume":"46","author":"Lam","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jtos.2020.09.001","article-title":"Latest evidences on meibomian gland dysfunction diagnosis and management","volume":"18","author":"Villani","year":"2020","journal-title":"Ocul Surf"},{"issue":"10","key":"10.1016\/j.jtos.2022.08.010_bib17","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/s41433-020-0876-2","article-title":"Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin","volume":"34","author":"Tao","year":"2020","journal-title":"Eye"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib18","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1167\/iovs.10-6997b","article-title":"The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee","volume":"52","author":"Nelson","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib19","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1167\/iovs.10-6997c","article-title":"The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland","volume":"52","author":"Knop","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib20","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1167\/iovs.10-6997a","article-title":"The international workshop on meibomian gland dysfunction: executive summary","volume":"52","author":"Nichols","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib21","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0002-9394(82)90365-8","article-title":"Histopathology of meibomian gland dysfunction","volume":"94","author":"Gutgesell","year":"1982","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2022.08.010_bib22","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1167\/iovs.10-6482","article-title":"Changes in gene expression in human meibomian gland dysfunction","volume":"52","author":"Liu","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib23","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jtos.2020.08.008","article-title":"A randomized, sham-controlled trial of intraductal meibomian gland probing with or without topical antibiotic\/steroid for obstructive meibomian gland dysfunction","volume":"18","author":"Kheirkhah","year":"2020","journal-title":"Ocul Surf"},{"issue":"14","key":"10.1016\/j.jtos.2022.08.010_bib24","doi-asserted-by":"crossref","first-page":"Des94","DOI":"10.1167\/iovs.17-23345","article-title":"Inflamed obstructive meibomian gland dysfunction causes ocular surface inflammation","volume":"59","author":"Suzuki","year":"2018","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib25","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1590\/S0004-27492012000300006","article-title":"Azithromycin 1.5% ophthalmic solution: efficacy and treatment modalities in chronic blepharitis","volume":"75","author":"Fadlallah","year":"2012","journal-title":"Arq Bras Oftalmol"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib26","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/BF00167872","article-title":"Blepharitis--a diagnostic and therapeutic challenge. A report on 407 consecutive cases","volume":"229","author":"Huber-Spitzy","year":"1991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.010_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2013.10.008","article-title":"Complexity of the tear film: importance in homeostasis and dysfunction during disease","volume":"117","author":"Dartt","year":"2013","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.immuni.2017.06.014","article-title":"An ocular commensal protects against corneal infection by driving an interleukin-17 response from mucosal \u03b3\u03b4 T cells","volume":"47","author":"St Leger","year":"2017","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.jtos.2022.08.010_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005855","article-title":"Impact of microbiota on resistance to ocular Pseudomonas aeruginosa-induced keratitis","volume":"12","author":"Kugadas","year":"2016","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib30","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40662-021-00228-4","article-title":"Strain heterogeneity, cooccurrence network, taxonomic composition and functional profile of the healthy ocular surface microbiome","volume":"8","author":"Kang","year":"2021","journal-title":"Eye Vis (Lond)."},{"issue":"5","key":"10.1016\/j.jtos.2022.08.010_bib31","article-title":"Interventions for chronic blepharitis","volume":"2012","author":"Lindsley","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib32","article-title":"The case for a more holistic approach to dry eye disease: is it time to move beyond antibiotics?","volume":"8","author":"Tavakoli","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"4731","key":"10.1016\/j.jtos.2022.08.010_bib33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/bmj.2.4731.582","article-title":"The treatment of blepharitis","volume":"2","author":"Ainslie","year":"1951","journal-title":"Br Med J"},{"key":"10.1016\/j.jtos.2022.08.010_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1749-6632.2011.06354.x","article-title":"The history of the tetracyclines","volume":"1241","author":"Nelson","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib35","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2174\/138955712798868977","article-title":"Tetracyclines: drugs with huge therapeutic potential","volume":"12","author":"Bahrami","year":"2012","journal-title":"Mini Rev Med Chem"},{"issue":"6","key":"10.1016\/j.jtos.2022.08.010_bib36","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.ajo.2012.06.009","article-title":"Minocycline controls clinical outcomes and inflammatory cytokines in moderate and severe meibomian gland dysfunction","volume":"154","author":"Lee","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib37","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1128\/MMBR.65.2.232-260.2001","article-title":"Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance","volume":"65","author":"Chopra","year":"2001","journal-title":"Microbiol Mol Biol Rev"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamaophthalmol.2013.5295","article-title":"Oral azithromycin for the treatment of meibomitis","volume":"132","author":"Greene","year":"2014","journal-title":"JAMA Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.4103\/ijo.IJO_1244_17","article-title":"Oral azithromycin and oral doxycycline for the treatment of Meibomian gland dysfunction: a 9-month comparative case series","volume":"67","author":"De Benedetti","year":"2019","journal-title":"Indian J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/bjophthalmol-2014-305410","article-title":"Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial","volume":"99","author":"Kashkouli","year":"2015","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.jtos.2022.08.010_bib41","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/ICO.0b013e318207fc42","article-title":"Oral azithromycin for treatment of posterior blepharitis","volume":"30","author":"Igami","year":"2011","journal-title":"Cornea"},{"key":"10.1016\/j.jtos.2022.08.010_bib42","article-title":"An eye for azithromycin: review of the literature","volume":"10","author":"Kagkelaris","year":"2018","journal-title":"Ther Adv Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.010_bib43","series-title":"Tetracycline. StatPearls. Treasure island (FL): StatPearls publishing Copyright \u00a9 2020","author":"Shutter","year":"2020"},{"key":"10.1016\/j.jtos.2022.08.010_bib44","series-title":"Macrolides. StatPearls. Treasure island (FL): StatPearls publishing Copyright \u00a9 2020","author":"Patel","year":"2020"},{"key":"10.1016\/j.jtos.2022.08.010_bib45","series-title":"Wills eye manual. Office and emergency room diagnose and treatment of eye disease","author":"Ehler","year":"2008"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib46","doi-asserted-by":"crossref","first-page":"258","DOI":"10.3341\/kjo.2005.19.4.258","article-title":"The effect of low-dose doxycycline therapy in chronic meibomian gland dysfunction","volume":"19","author":"Yoo","year":"2005","journal-title":"Kor J Ophthalmol"},{"issue":"6","key":"10.1016\/j.jtos.2022.08.010_bib47","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1007\/s00417-019-04322-1","article-title":"Efficacy of azithromycin 1.5% eyedrops vs oral doxycycline in meibomian gland dysfunction: a randomized trial","volume":"257","author":"Satitpitakul","year":"2019","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jtos.2022.08.010_bib48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2147\/OPTH.S150433","article-title":"Comparison of a single-dose vectored thermal pulsation procedure with a 3-month course of daily oral doxycycline for moderate-to-severe meibomian gland dysfunction","volume":"12","author":"Hagen","year":"2018","journal-title":"Clin Ophthalmol"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib49","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1089\/jop.2017.0095","article-title":"Comparison of the clinical efficacy of topical and systemic azithromycin treatment for posterior blepharitis","volume":"34","author":"Yildiz","year":"2018","journal-title":"J Ocul Pharmacol Therapeut"},{"issue":"9","key":"10.1016\/j.jtos.2022.08.010_bib50","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s12325-008-0096-9","article-title":"Efficacy of topical azithromycin ophthalmic solution 1% in the treatment of posterior blepharitis","volume":"25","author":"Luchs","year":"2008","journal-title":"Adv Ther"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/ICL.0000000000000729","article-title":"Efficacy of azithromycin eyedrops for individuals with meibomian gland dysfunction-associated posterior blepharitis","volume":"47","author":"Arita","year":"2021","journal-title":"Eye Contact Lens"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib52","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICO.0000000000002233","article-title":"The role of topical azithromycin in the treatment of meibomian gland dysfunction","volume":"39","author":"Ciloglu","year":"2020","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.jtos.2022.08.010_bib53","first-page":"1016","article-title":"Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis","volume":"9","author":"Zandian","year":"2016","journal-title":"Int J Ophthalmol"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib54","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1444-0938.2010.00540.x","article-title":"Efficacy of azithromycin 1% ophthalmic solution for treatment of ocular surface disease from posterior blepharitis","volume":"94","author":"Opitz","year":"2011","journal-title":"Clin Exp Optom"},{"issue":"8","key":"10.1016\/j.jtos.2022.08.010_bib55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/ICO.0b013e3181ca38a0","article-title":"Multicenter open-label study evaluating the efficacy of azithromycin ophthalmic solution 1% on the signs and symptoms of subjects with blepharitis","volume":"29","author":"Haque","year":"2010","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.jtos.2022.08.010_bib56","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/bjo.2007.133900","article-title":"Changes in meibomian fatty acids and clinical signs in patients with meibomian gland dysfunction after minocycline treatment","volume":"92","author":"Souchier","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"10.1016\/j.jtos.2022.08.010_bib57","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1177\/112067210901900504","article-title":"In vivo characterization of doxycycline effects on tear metalloproteinases in patients with chronic blepharitis","volume":"19","author":"Iovieno","year":"2009","journal-title":"Eur J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2022.08.010_bib58","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1136\/bjo.2006.091579","article-title":"Short term oral minocycline treatment of meibomianitis","volume":"90","author":"Aronowicz","year":"2006","journal-title":"Br J Ophthalmol"},{"issue":"7","key":"10.1016\/j.jtos.2022.08.010_bib59","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1097\/ICO.0b013e3181cda38f","article-title":"Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations","volume":"29","author":"Foulks","year":"2010","journal-title":"Cornea"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib60","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/ICO.0b013e318254205f","article-title":"Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study","volume":"32","author":"Foulks","year":"2013","journal-title":"Cornea"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib61","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0014-4835(03)00005-8","article-title":"Minocycline effect on meibomian gland lipids in meibomianitis patients","volume":"76","author":"Shine","year":"2003","journal-title":"Exp Eye Res"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib62","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/cxo.12557","article-title":"Assessment of efficacy of topical azithromycin 1.5 per cent ophthalmic solution for the treatment of meibomian gland dysfunction","volume":"101","author":"Balci","year":"2018","journal-title":"Clin Exp Optom"},{"key":"10.1016\/j.jtos.2022.08.010_bib63","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bcp.2016.09.007","article-title":"Antibiotic use and microbiome function","volume":"134","author":"Ferrer","year":"2017","journal-title":"Biochem Pharmacol"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.VMBF-0016-2015","article-title":"Mechanisms of antibiotic resistance","volume":"4","author":"Munita","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib65","first-page":"118","article-title":"A status report on the use of subantimicrobial-dose doxycycline: a review of the biologic and antimicrobial effects of the tetracyclines","volume":"74","author":"Del Rosso","year":"2004","journal-title":"Cutis"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib66","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1001\/archderm.139.4.459","article-title":"Effects of subantimicrobial-dose doxycycline in the treatment of moderate acne","volume":"139","author":"Skidmore","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jtos.2022.08.010_bib67","first-page":"129","article-title":"Safety and efficacy of doxycycline in the treatment of rosacea","volume":"2","author":"Valent\u00edn","year":"2009","journal-title":"Clin Cosmet Invest Dermatol"},{"key":"10.1016\/j.jtos.2022.08.010_bib68","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2147\/IDR.S173867","article-title":"Antibiotic resistance: a rundown of a global crisis","volume":"11","author":"Aslam","year":"2018","journal-title":"Infect Drug Resist"},{"issue":"6","key":"10.1016\/j.jtos.2022.08.010_bib69","article-title":"A review on antibiotic resistance: alarm bells are ringing","volume":"9","author":"Zaman","year":"2017","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.jtos.2022.08.010_bib70","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/08830185.2012.748052","article-title":"Dry eye as a mucosal autoimmune disease","volume":"32","author":"Stern","year":"2013","journal-title":"Int Rev Immunol"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib71","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.exer.2006.02.004","article-title":"Corticosteroid and doxycycline suppress MMP-9 and inflammatory cytokine expression, MAPK activation in the corneal epithelium in experimental dry eye","volume":"83","author":"De Paiva","year":"2006","journal-title":"Exp Eye Res"},{"issue":"Suppl 2","key":"10.1016\/j.jtos.2022.08.010_bib72","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1097\/ICL.0000000000000668","article-title":"Role of matrix metalloproteinase 9 in ocular surface disorders","volume":"46","author":"Jamerson","year":"2020","journal-title":"Eye Contact Lens"},{"issue":"7","key":"10.1016\/j.jtos.2022.08.010_bib73","doi-asserted-by":"crossref","first-page":"2847","DOI":"10.1167\/iovs.05-1281","article-title":"Apical corneal barrier disruption in experimental murine dry eye is abrogated by methylprednisolone and doxycycline","volume":"47","author":"De Paiva","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.jtos.2022.08.010_bib74","first-page":"2544","article-title":"Doxycycline inhibition of interleukin-1 in the corneal epithelium","volume":"41","author":"Solomon","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"10.1016\/j.jtos.2022.08.010_bib75","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00003226-200308000-00011","article-title":"Effects of minocycline on the ocular flora of patients with acne rosacea or seborrheic blepharitis","volume":"22","author":"Ta","year":"2003","journal-title":"Cornea"},{"issue":"11","key":"10.1016\/j.jtos.2022.08.010_bib76","first-page":"2970","article-title":"The role of tetracycline in chronic blepharitis. Inhibition of lipase production in staphylococci","volume":"32","author":"Dougherty","year":"1991","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"10.1016\/j.jtos.2022.08.010_bib77","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/02713683.2019.1570526","article-title":"The ocular microbiome: molecular characterisation of a unique and low microbial environment","volume":"44","author":"Ozkan","year":"2019","journal-title":"Curr Eye Res"},{"issue":"22","key":"10.1016\/j.jtos.2022.08.010_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21228443","article-title":"Can gut microbiota affect dry eye syndrome?","volume":"21","author":"Moon","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jtos.2022.08.010_bib79","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/ICL.0b013e31823ff229","article-title":"Safety and efficacy of topical azithromycin ophthalmic solution 1.0% in the treatment of contact lens-related dry eye","volume":"38","author":"Nichols","year":"2012","journal-title":"Eye Contact Lens"},{"issue":"4","key":"10.1016\/j.jtos.2022.08.010_bib80","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"10.1016\/j.jtos.2022.08.010_bib81","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1097\/ICO.0000000000000351","article-title":"Can tetracycline antibiotics duplicate the ability of azithromycin to stimulate human meibomian gland epithelial cell differentiation?","volume":"34","author":"Liu","year":"2015","journal-title":"Cornea"}],"container-title":["The Ocular Surface"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542012422000829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T04:49:37Z","timestamp":1761540577000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542012422000829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":81,"alternative-id":["S1542012422000829"],"URL":"https:\/\/doi.org\/10.1016\/j.jtos.2022.08.010","relation":{},"ISSN":["1542-0124"],"issn-type":[{"value":"1542-0124","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibiotic treatment for dry eye disease related to meibomian gland dysfunction and blepharitis \u2013 A review","name":"articletitle","label":"Article Title"},{"value":"The Ocular Surface","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtos.2022.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}